Moreover, it has been found that BRAFV600E-mutant human melanoma cell lines increased the expression of vascular endothelial growth factor (VEGF), which may favor a tolerogenic DC phenotype and tumor progression by neoangiogenesis [43,47]. The gene discussed is VEGFA; the disease is neoplasm.